Evidence map›Paper›PMID 24709702›Full record

ArticleCells2013

Morphological Features of Organelles during Apoptosis: An Overview.

Maria Grazia Bottone, Giada Santin, Francesca Aredia, Graziella Bernocchi, Carlo Pellicciari, Anna Ivana Scovassi

Abstract read
In one paragraph

Article in Cells, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Sensitivity analysis of EGFR L861Q mutation to six tyrosine kinase inhibitors.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. 7-Biomolecules · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria Grazia BottoneLaboratorio di Biologia Cellulare e Neurobiologia, Dipartimento di Biologia e Biotecnologie "L. Spallanzani", Università di Pavia, 27100 Pavia, Italy. aredia@igm.cnr.it.
Giada SantinLaboratorio di Biologia Cellulare e Neurobiologia, Dipartimento di Biologia e Biotecnologie "L. Spallanzani", Università di Pavia, 27100 Pavia, Italy. aredia@igm.cnr.it.
Francesca ArediaIstituto di Genetica Molecolare CNR, 27100 Pavia, Italy. aredia@igm.cnr.it.
Graziella BernocchiLaboratorio di Biologia Cellulare e Neurobiologia, Dipartimento di Biologia e Biotecnologie "L. Spallanzani", Università di Pavia, 27100 Pavia, Italy. graziella.bernocchi@unipv.it.
Carlo PellicciariLaboratorio di Biologia Cellulare e Neurobiologia, Dipartimento di Biologia e Biotecnologie "L. Spallanzani", Università di Pavia, 27100 Pavia, Italy. pelli@unipv.it.
Anna Ivana ScovassiIstituto di Genetica Molecolare CNR, 27100 Pavia, Italy. scovassi@igm.cnr.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An apoptotic program leading to controlled cell dismantling implies perturbations of nuclear dynamics, as well as changes affecting the organelle structure and distribution. In human cancer cells driven to apoptosis by different stimuli, we have recently investigated the morphological properties of several organelles, including mitochondria, lysosomes, endoplasmic reticulum and Golgi apparatus. In this review, we will discuss the body of evidence in the literature suggesting that organelles are generally relocated and/or degraded during apoptosis, irrespectively of the apoptogenic stimulus and cell type.

Identifiers

PMID24709702
PMCPMC3972681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.